Search research articles
Contact Us
Filters
Showing results (51-60 of 172) with videos related to
Page
of 18
Sort By:
British Journal of Cancer
|
August 25, 2022
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE
Geoffrey A Watson, Zachary W Veitch, Daniel Shepshelovich, et al.
British Journal of Cancer
|
March 1, 2023
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma
Abhenil Mittal, Esmail Al-Ezzi, Xuan Li, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 28, 2014
Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma
Aaron R Hansen, Brett Gm Hughes, Sanjoy Paul, et al.
Urologic Oncology
|
June 20, 2020
Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice
Noelia Sanmamed, Rachel M Glicksman, Jaime Herrera-Caceres, et al.
Epigenomics
|
July 12, 2022
A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer
Madonna R Peter, Misha Bilenky, Yuliang Shi, et al.
Journal of Kidney Cancer and VHL
|
March 7, 2024
The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience
Esmail Al-Ezzi, Abhenil Mittal, Zachary W Veitch, et al.
Analytical Chemistry
|
July 3, 2019
Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking
Brenda J Green, Vivian Nguyen, Eshetu Atenafu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2023
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients
Kirsty Taylor, Jinfeng Zou, Marcos Magalhaes, et al.
Cancer Immunology, Immunotherapy : CII
|
February 13, 2024
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors
John F Hilton, Patrick A Ott, Aaron R Hansen, et al.
JCO Precision Oncology
|
April 7, 2023
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials
Enrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 172) with videos related to
Sort By:
Page
of 18
British Journal of Cancer
|
August 25, 2022
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE
Geoffrey A Watson, Zachary W Veitch, Daniel Shepshelovich, et al.
British Journal of Cancer
|
March 1, 2023
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma
Abhenil Mittal, Esmail Al-Ezzi, Xuan Li, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 28, 2014
Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma
Aaron R Hansen, Brett Gm Hughes, Sanjoy Paul, et al.
Urologic Oncology
|
June 20, 2020
Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice
Noelia Sanmamed, Rachel M Glicksman, Jaime Herrera-Caceres, et al.
Epigenomics
|
July 12, 2022
A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer
Madonna R Peter, Misha Bilenky, Yuliang Shi, et al.
Journal of Kidney Cancer and VHL
|
March 7, 2024
The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience
Esmail Al-Ezzi, Abhenil Mittal, Zachary W Veitch, et al.
Analytical Chemistry
|
July 3, 2019
Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking
Brenda J Green, Vivian Nguyen, Eshetu Atenafu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2023
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients
Kirsty Taylor, Jinfeng Zou, Marcos Magalhaes, et al.
Cancer Immunology, Immunotherapy : CII
|
February 13, 2024
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors
John F Hilton, Patrick A Ott, Aaron R Hansen, et al.
JCO Precision Oncology
|
April 7, 2023
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials
Enrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, et al.
Page
of 18